Perth-based Eastland Medical Systems Ltd has moved to the next commercialisation phase of an anti-malaria treatment it believes could deliver more than $250 million in sales each year.

Perth-based Eastland Medical Systems Ltd has moved to the next commercialisation phase of an anti-malaria treatment it believes could deliver more than $250 million in sales each year.